
KI-TOX-A3 is a селективный protein-protein interaction (PPI) ингибитор targeting TOX protein (with an IC50 value of 0.51 μM for TOX-KAT7 interaction). KI-TOX-A3 induces proteasomal degradation of TOX, restores KAT7-mediated H3K14 acetylation, reversing CD8+ T клетка exhaustion and inhibiting T-клетка acute lymphoblastic leukemia (T-ALL) клетка proliferation. KI-TOX-A3 is promising for research of hematological tumors (e.g., T-ALL).
KI-TOX-A3 is a selective protein-protein interaction (PPI) inhibitor targeting TOX protein (with an IC50 value of 0.51 μM for TOX-KAT7 interaction). KI-TOX-A3 induces proteasomal degradation of TOX, restores KAT7-mediated H3K14 acetylation, reversing CD8+ T cell exhaustion and inhibiting T-cell acute lymphoblastic leukemia (T-ALL) cell proliferation. KI-TOX-A3 is promising for research of hematological tumors (e.g., T-ALL).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.